liberDi

Or Akiva, Israel Founded: 2014 • Age: 12 yrs
Portable peritoneal dialysis systems are developed for end-stage kidney patients.

About liberDi

liberDi is a Healthcare company based in Or Akiva (Israel) founded in 2014. Portable peritoneal dialysis systems are developed for end-stage kidney patients. liberDi has raised $1.13 million across 4 funding rounds from investors including European Union and Medimor. Its chief executive, as recorded, is Hezkiah Tsoory. liberDi offers products and services including Digital Dialysis Clinic and Intelligent Dialysis Assistant (iDA). Its focus areas include Life Sciences, Nephrology, Medical Devices and Therapeutic Devices. Its legal entity is liberDi Ltd.

Company details

Founded in 2014 in Or Akiva, Israel, LiberDi operates in the medical device sector, focusing on portable automatic peritoneal dialysis systems for end-stage renal disease patients. The flagship product supports bedside catheter installation and addresses catheter-related leaks. Its lightweight and compact design enables patients to conduct dialysis independently. Operations emphasize safe, user-friendly renal care solutions.

  • Headquarters Or Akiva, Israel
  • Sectors
    Healthcare
  • Website liberdi.com
  • Social LinkedIn
  • Legal Name Liberdi Ltd.
Operational Areas
Key Metrics
  • Total Equity Funding
    $1.13M (USD)

    in 4 rounds

  • Latest Funding Round
    $100K (USD), Grant

    Oct 2021

  • Investors

Products & Services of liberDi

liberDi offers a comprehensive portfolio of products and services, including Digital Dialysis Clinic and Intelligent Dialysis Assistant (iDA).

Digital Dialysis Clinic
Medical Device

Platform for safe and effective home peritoneal dialysis.

Intelligent Dialysis Assistant (iDA)
Dialysis Device

Automated device for ambulatory PD exchanges at home.

Funding Insights of liberDi

liberDi has successfully raised a total of $1.13M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $100 thousand completed in October 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $1.13M
  • Total Rounds 4
  • Last Round Grant β€” $100,000
  • First Round $58,318

    (Aug 2018)

  • Investors Count 2

All 4 funding rounds of liberDi with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2021$100,000Grant––
Sep 2019$2.37MGrant––
Jul 2019$1.13MSeed––
–
Aug 2018$58,318Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in liberDi

liberDi has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Medimor.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Medimor is engaged in providing manufacturing solutions for medical markets.
medimor.comTiberias, Israel
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for liberDi

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of liberDi

1 people are tracked at liberDi (1 in leadership).

NameRoleGroup
Hezkiah Tsoory
CEOLeadership
Premium access

Complete people profiles for liberDi

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of liberDi

3 dated milestones of liberDi across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded liberDi is founded.
  2. Funding First funding round of $58K.
  3. Funding Latest funding round, Grant, of $100K.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Liberdi

Premium access

Complete news archive for liberDi

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about liberDi

liberDi was founded in 2014 and raised its 1st funding round 4 years after it was founded.

liberDi is headquartered in Or Akiva, Israel. It is registered at Or Akiva, Central District, Israel.

Hezkiah Tsoory is the CEO of liberDi, as recorded in our data.

liberDi is a funded company, having raised a total of $1.13M across 4 funding rounds to date. The company's 1st funding round was a Grant of $58.32K, raised on Aug 2018.

Founded in 2014 in Or Akiva, Israel, LiberDi operates in the medical device sector, focusing on portable automatic peritoneal dialysis systems for end-stage renal disease patients. The flagship product supports bedside catheter installation and addresses catheter-related leaks. Its lightweight and compact design enables patients to conduct dialysis independently. Operations emphasize safe, user-friendly renal care solutions.

liberDi offers Digital Dialysis Clinic and Intelligent Dialysis Assistant (iDA).

liberDi has 2 investors. Key investors include European Union, and Medimor.

liberDi operates through Liberdi Ltd..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available